Stephens Investment Management Group LLC lifted its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 24.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,486 shares of the biotechnology company’s stock after acquiring an additional 20,262 shares during the period. Stephens Investment Management Group LLC’s holdings in Axon Enterprise were worth $43,949,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in AXON. Creative Financial Designs Inc. ADV purchased a new stake in Axon Enterprise during the 4th quarter worth about $28,000. Sound Income Strategies LLC grew its holdings in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares in the last quarter. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at about $30,000. AlphaCentric Advisors LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at about $34,000. Finally, Lodestone Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth about $35,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Axon Enterprise Stock Performance
Shares of AXON stock opened at $597.04 on Friday. The business has a 50-day moving average price of $437.68 and a two-hundred day moving average price of $482.40. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The firm has a market cap of $48.12 billion, a P/E ratio of 239.78, a price-to-earnings-growth ratio of 12.18 and a beta of 1.38.
Wall Street Analyst Weigh In
Several brokerages have commented on AXON. Piper Sandler reissued an “overweight” rating and issued a $674.00 price target on shares of Axon Enterprise in a report on Monday, June 15th. UBS Group lowered their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday, May 7th. Weiss Ratings upgraded Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Zacks Research upgraded Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. Finally, Barclays lowered their price target on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $712.75.
View Our Latest Stock Analysis on Axon Enterprise
Insider Buying and Selling at Axon Enterprise
In related news, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the transaction, the president owned 169,125 shares in the company, valued at $82,609,106.25. This trade represents a 7.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 20,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the sale, the chief executive officer owned 3,060,997 shares of the company’s stock, valued at approximately $1,530,498,500. The trade was a 0.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 48,989 shares of company stock valued at $24,090,083. 4.20% of the stock is currently owned by corporate insiders.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
- Five stocks we like better than Axon Enterprise
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
